Weight Loss
Tirzepatide 10mg
$70.00 CAD
In stock · Purity 99.7% · Ships within Canada · Interac e-Transfer
Description
Tirzepatide changed the conversation around metabolic health by combining the activity of two naturally occurring hormones—GIP and GLP-1. Together, these hormones help regulate appetite, improve the body's insulin response, slow stomach emptying, and promote longer-lasting feelings of fullness after eating.
Its dual-action design has made Tirzepatide one of the most significant advances in metabolic medicine in recent years. Beyond blood sugar regulation, researchers have observed meaningful effects on weight management and improvements in several markers associated with metabolic health. Rather than acting as a stimulant, Tirzepatide works alongside the body's own hormone signaling, supporting a more natural approach to appetite and glucose regulation.
Interesting Fact: Tirzepatide was the world's first approved medication to combine both GIP and GLP-1 receptor activity, opening the door to an entirely new class of metabolic therapies.
Compliance
For laboratory research use only. Not for human or veterinary use, diagnostic, or therapeutic application. By purchasing you confirm you are a qualified researcher.
Quality & testing
Research guide
Tirzepatide (LY3298176) is a synthetic acylated peptide that acts as a dual agonist at both the glucose-dependent insulinotropic polypeptide (GIP) receptor and the glucagon-like peptide-1 (GLP-1) receptor. It is studied primarily in the context of obesity, type 2 diabetes (T2DM), metabolic liver disease, and cardiovascular conditions such as heart failure with preserved ejection fraction (HFpEF). Research indicates it produces greater reductions in body weight and blood glucose than selective GLP-1 receptor agonists across multiple large-scale clinical trials.
Published studies
- Tirzepatide for Obesity Treatment and Diabetes Prevention (SURMOUNT-1 Three-Year Analysis)
- Tirzepatide for Heart Failure with Preserved Ejection Fraction and Obesity
- Tirzepatide for Metabolic Dysfunction-Associated Steatohepatitis with Liver Fibrosis (SYNERGY-NASH Trial)
- Tirzepatide for Metabolic Dysfunction–Associated Steatohepatitis with Liver Fibrosis
- Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity
Other sizes
- Tirzepatide 20mg — $110.00 CAD
Frequently asked questions
What does Eternal Biolabs sell?
Research-grade peptides and laboratory supplies for in-vitro and laboratory research use only, shipped within Canada. Products are not for human or veterinary use.
Are the peptides third-party tested?
Yes. Products are independently tested and certificates of analysis (purity, lot and test date) are published on the Lab Results page.
How do I pay?
Checkout uses Interac e-Transfer. Orders stay pending until the transfer matching the exact order total is received, then they are verified and shipped.
Cite this page
Eternal Biolabs Research Desk (2026). Tirzepatide 10mg. Eternal Biolabs. https://eternalbiolabs.ca/api/g/product/aeabcb35-f280-4096-b6f8-88b7d9c5116d Last reviewed 2026-06-18.
For laboratory research use only. Nothing on this page is medical advice, dosing guidance, or an instruction for human or veterinary use.